Jonas Eberhard
46 – 58 of 58
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2007
-
Mark
Costs of schizophrenia during five years
(
- Contribution to journal › Article
-
Mark
Factors predicting patient withdrawal from long-term treatment of schizophrenia
(
- Contribution to journal › Published meeting abstract
-
Mark
Nicotine use and its correlates in patients with psychosis
(
- Contribution to journal › Article
-
Mark
Identification of potential predictors of sertindole response in patients with schizophrenia
(
- Contribution to journal › Published meeting abstract
-
Mark
Outcome evaluation needed to support evidence-based practice! Preface
(
- Contribution to journal › Article
-
Mark
SCHIZOPHRENIA IN A LONGITUDINAL PERSPECTIVE clinical and neurocognitive aspects
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome
(
- Contribution to journal › Article
- 2006
-
Mark
Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course.
(
- Contribution to journal › Article
-
Mark
Cognition and schizophrenia: improving real life function
2006)(
- Book/Report › Book
- 2005
-
Mark
QTc interval prolongation and antipsychotic drug treatments: focus on sertindole
(
- Contribution to journal › Scientific review
-
Mark
Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics.
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Premorbid IQ and schizophrenia Increasing cognitive reduction by episodes.
(
- Contribution to journal › Article
- 1998
-
Mark
Social cognition, symptom profile, and quality of life in schizophrenia
(
- Contribution to journal › Published meeting abstract
- « previous
- 1
- 2
- 3
- 4
- next »